{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:40:10Z","timestamp":1793032810206,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Major Science and Technology Projects in Henan Province","award":["241110310300"],"award-info":[{"award-number":["241110310300"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00203-026-05048-5","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:33:52Z","timestamp":1785908032000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification and computational analysis of B-cell epitopes on the hemagglutinin protein of the H3N2 influenza virus"],"prefix":"10.1007","volume":"208","author":[{"given":"Mengyuan","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sixuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xifang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1661-8174","authenticated-orcid":false,"given":"Aiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"issue":"6","key":"5048_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.112451","volume":"28","author":"M Afzal","year":"2025","unstructured":"Afzal M, Melnyk D, Courty T, Schimanski L, Hill M, Neil S, Tan TK, James WS (2025) Determination of resilience of a panel of broadly neutralizing mAbs to emerging variants of SARS-CoV-2 generated using reverse genetics. iScience 28(6):112451. https:\/\/doi.org\/10.1016\/j.isci.2025.112451","journal-title":"iScience"},{"issue":"8","key":"5048_CR2","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1080\/21645515.2018.1462639","volume":"14","author":"JD Allen","year":"2018","unstructured":"Allen JD, Ross TM (2018) H3N2 influenza viruses in humans: viral mechanisms, evolution, and evaluation. Hum Vaccin Immunother 14(8):1840\u20131847. https:\/\/doi.org\/10.1080\/21645515.2018.1462639","journal-title":"Hum Vaccin Immunother"},{"issue":"8","key":"5048_CR3","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1099\/jgv.0.001101","volume":"99","author":"K Beer","year":"2018","unstructured":"Beer K, Dai M, Howell S, Rijal P, Townsend AR, Lin Y, Wharton SA, Daniels RS, McCauley JW (2018) Characterization of neutralizing epitopes in antigenic site B of recently circulating influenza A(H3N2) viruses. J Gen Virol 99(8):1001\u20131011. https:\/\/doi.org\/10.1099\/jgv.0.001101","journal-title":"J Gen Virol"},{"issue":"Supplement_3","key":"5048_CR4","doi-asserted-by":"publisher","first-page":"S347","DOI":"10.1093\/infdis\/jiaf216","volume":"232","author":"JH Beigel","year":"2025","unstructured":"Beigel JH, Oldach D (2025) Polyclonal and monoclonal antibodies for the treatment and prevention of influenza. J Infect Dis 232(Supplement_3):S347-s358. https:\/\/doi.org\/10.1093\/infdis\/jiaf216","journal-title":"J Infect Dis"},{"issue":"3","key":"5048_CR5","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1080\/21645515.2017.1363135","volume":"14","author":"CM Berry","year":"2018","unstructured":"Berry CM (2018) Antibody immunoprophylaxis and immunotherapy for influenza virus infection: utilization of monoclonal or polyclonal antibodies? Hum Vaccin Immunother 14(3):796\u2013799. https:\/\/doi.org\/10.1080\/21645515.2017.1363135","journal-title":"Hum Vaccin Immunother"},{"key":"5048_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/intbio\/zyaf018","volume":"17","author":"R Biswas","year":"2025","unstructured":"Biswas R, Anbarasu A (2025) Identification of novel zinc-binding inhibitors against key microbial metallohydrolase DapE in Klebsiella pneumoniae: an integrated ligand-based virtual screening, molecular docking, molecular dynamics, and MM\/PBSA approach. Integr Biol 17:zyaf018. https:\/\/doi.org\/10.1093\/intbio\/zyaf018","journal-title":"Integr Biol"},{"key":"5048_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2024.101782","volume":"87","author":"R Biswas","year":"2024","unstructured":"Biswas R, Swetha RG, Basu S, Roy A, Ramaiah S, Anbarasu A (2024) Designing multi-epitope vaccine against human cytomegalovirus integrating pan-genome and reverse vaccinology pipelines. Biologicals 87:101782. https:\/\/doi.org\/10.1016\/j.biologicals.2024.101782","journal-title":"Biologicals"},{"issue":"1","key":"5048_CR8","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2026.2626088","volume":"22","author":"R Biswas","year":"2026","unstructured":"Biswas R, Roy A, Kayal T, Basu S, Ghosh S, Ramaiah S, Anbarasu A (2026) Waning immunity and the future of booster vaccination strategies in global vaccine programs post COVID-19. Hum Vaccin Immunother 22(1):2626088. https:\/\/doi.org\/10.1080\/21645515.2026.2626088","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"5048_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-23648-6","volume":"25","author":"M Chen","year":"2025","unstructured":"Chen M, Yang M, Yan R, Liu Z, Chen C, Qu R, Zhou W, Qi J, Cao K, Miao J, Wu X, Chen J, Feng Q, Zhang H, Dai A, Yang Y, Zhou J, Chen Q, Sun J, Yang S (2025) The optimal strategy for seasonal influenza vaccination to prevent high-intensity level of influenza epidemics in Zhejiang, China: an integrated transmission-dynamic and health-economic modeling analysis. BMC Public Health 25(1):2459. https:\/\/doi.org\/10.1186\/s12889-025-23648-6","journal-title":"BMC Public Health"},{"issue":"1","key":"5048_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00253-020-11035-7","volume":"105","author":"YC Cheng","year":"2021","unstructured":"Cheng YC, Chang SC (2021) Development and biochemical characterization of the monoclonal antibodies for specific detection of the emerging H5N8 and H5Nx avian influenza virus hemagglutinins. Appl Microbiol Biotechnol 105(1):235\u2013245. https:\/\/doi.org\/10.1007\/s00253-020-11035-7","journal-title":"Appl Microbiol Biotechnol"},{"issue":"6044","key":"5048_CR11","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1205669","volume":"333","author":"D Corti","year":"2011","unstructured":"Corti D, Voss J, Gamblin SJ, Codoni G, Macagno A, Jarrossay D, Vachieri SG, Pinna D, Minola A, Vanzetta F, Silacci C, Fernandez-Rodriguez BM, Agatic G, Bianchi S, Giacchetto-Sasselli I, Calder L, Sallusto F, Collins P, Haire LF, Temperton N, Langedijk JP, Skehel JJ, Lanzavecchia A (2011) A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333(6044):850\u2013856. https:\/\/doi.org\/10.1126\/science.1205669","journal-title":"Science"},{"key":"5048_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1483720","volume":"15","author":"Y Di","year":"2024","unstructured":"Di Y, Zhang C, Ren Z, Jiang R, Tang J, Yang S, Wang Z, Yu T, Zhang T, Yu Z, Xu Z, Zhuang X, Jin N, Tian M (2024) The self-assembled nanoparticle-based multi-epitope influenza mRNA vaccine elicits protective immunity against H1N1 and B influenza viruses in mice. Front Immunol 15:1483720. https:\/\/doi.org\/10.3389\/fimmu.2024.1483720","journal-title":"Front Immunol"},{"issue":"2","key":"5048_CR13","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1172\/jci84428","volume":"126","author":"DJ DiLillo","year":"2016","unstructured":"DiLillo DJ, Palese P, Wilson PC, Ravetch JV (2016) Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection. J Clin Invest 126(2):605\u2013610. https:\/\/doi.org\/10.1172\/jci84428","journal-title":"J Clin Invest"},{"issue":"5924","key":"5048_CR14","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1126\/science.1171491","volume":"324","author":"DC Ekiert","year":"2009","unstructured":"Ekiert DC, Bhabha G, Elsliger MA, Friesen RH, Jongeneelen M, Throsby M, Goudsmit J, Wilson IA (2009) Antibody recognition of a highly conserved influenza virus epitope. Science 324(5924):246\u2013251. https:\/\/doi.org\/10.1126\/science.1171491","journal-title":"Science"},{"key":"5048_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.puhe.2024.02.027","volume":"230","author":"C Galli","year":"2024","unstructured":"Galli C, Mazzola G, Arosio M, Pellegrinelli L, Boldrini A, Guarneri D, Lombarda E, Farina C, Cereda D, Pariani E (2024) Real-time investigation of an influenza A(H3N2) virus outbreak in a refugee community, November 2022. Public Health (Oxf) 230:157\u2013162. https:\/\/doi.org\/10.1016\/j.puhe.2024.02.027","journal-title":"Public Health (Oxf)"},{"issue":"4","key":"5048_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.bj.2018.08.002","volume":"41","author":"YN Gong","year":"2018","unstructured":"Gong YN, Kuo RL, Chen GW, Shih SR (2018) Centennial review of influenza in Taiwan. Biomed J 41(4):234\u2013241. https:\/\/doi.org\/10.1016\/j.bj.2018.08.002","journal-title":"Biomed J"},{"issue":"5","key":"5048_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7305a1","volume":"73","author":"LA Grohskopf","year":"2024","unstructured":"Grohskopf LA, Ferdinands JM, Blanton LH, Broder KR, Loehr J (2024) Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices - United States, 2024\u201325 influenza season. MMWR Recomm Rep 73(5):1\u201325. https:\/\/doi.org\/10.15585\/mmwr.rr7305a1","journal-title":"MMWR Recomm Rep"},{"issue":"22","key":"5048_CR18","doi-asserted-by":"publisher","first-page":"20824","DOI":"10.1021\/acsnano.5c03199","volume":"19","author":"M Hao","year":"2025","unstructured":"Hao M, Wang Y, Yang W, Xu M, Guan Y, Zhang Y, Chen J (2025) Epitope-optimized influenza hemagglutinin nanoparticle vaccine provides broad cross-reactive immunity against H9N2 influenza virus. ACS Nano 19(22):20824\u201320840. https:\/\/doi.org\/10.1021\/acsnano.5c03199","journal-title":"ACS Nano"},{"issue":"1","key":"5048_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-65283-0","volume":"16","author":"G Hoy","year":"2025","unstructured":"Hoy G, Cortier T, Maier HE, Kuan G, Lopez R, Sanchez N, Ojeda S, Plazaola M, Stadlbauer D, Shotwell A, Balmaseda A, Krammer F, Cauchemez S, Gordon A (2025) Anti-neuraminidase and anti-HA stalk antibodies reduce the susceptibility to and infectivity of influenza A\/H3N2 virus. Nat Commun 16(1):10910. https:\/\/doi.org\/10.1038\/s41467-025-65283-0","journal-title":"Nat Commun"},{"issue":"13","key":"5048_CR20","doi-asserted-by":"publisher","first-page":"7130","DOI":"10.1128\/jvi.00420-14","volume":"88","author":"Y Iba","year":"2014","unstructured":"Iba Y, Fujii Y, Ohshima N, Sumida T, Kubota-Koketsu R, Ikeda M, Wakiyama M, Shirouzu M, Okada J, Okuno Y, Kurosawa Y, Yokoyama S (2014) Conserved neutralizing epitope at globular head of hemagglutinin in H3N2 influenza viruses. J Virol 88(13):7130\u20137144. https:\/\/doi.org\/10.1128\/jvi.00420-14","journal-title":"J Virol"},{"issue":"1","key":"5048_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-83026-x","volume":"14","author":"J Ji","year":"2024","unstructured":"Ji J, Chen L, Wu Z, Tang T, Zhu L, Zhu M, Chen Y, Lu X, Yao H (2024) Enhancing antibody levels and T cell activity of quadrivalent influenza vaccine by combining it with CpG HP021. Sci Rep 14(1):31424. https:\/\/doi.org\/10.1038\/s41598-024-83026-x","journal-title":"Sci Rep"},{"issue":"1","key":"5048_CR22","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2484088","volume":"21","author":"B Kandinov","year":"2025","unstructured":"Kandinov B, Soens M, Huang W, Llapur C, Ensz D, Essink B, Fierro C, Vakil J, Pucci A, Guo J, Rudden S, Hall K, Hicks B, Schaefers K, Zhou H, Ma C, Zheng L, Avanesov A, Park Y, Du E, Miller J, Ananworanich J, Nachbagauer R (2025) An mRNA-based seasonal influenza vaccine in adults: results of two phase 3 randomized clinical trials and correlate of protection analysis of hemagglutination inhibition titers. Hum Vaccin Immunother 21(1):2484088. https:\/\/doi.org\/10.1080\/21645515.2025.2484088","journal-title":"Hum Vaccin Immunother"},{"issue":"1\u20133","key":"5048_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/15257770.2019.1671593","volume":"39","author":"D Kawaguchi","year":"2020","unstructured":"Kawaguchi D, Shimizu S, Abe N, Hashiya F, Tomoike F, Kimura Y, Abe H (2020) Translational control by secondary-structure formation in mRNA in a eukaryotic system. Nucleosides Nucleotides Nucleic Acids 39(1\u20133):195\u2013203. https:\/\/doi.org\/10.1080\/15257770.2019.1671593","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"3","key":"5048_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nrd4529","volume":"14","author":"F Krammer","year":"2015","unstructured":"Krammer F, Palese P (2015) Advances in the development of influenza virus vaccines. Nat Rev Drug Discov 14(3):167\u2013182. https:\/\/doi.org\/10.1038\/nrd4529","journal-title":"Nat Rev Drug Discov"},{"key":"5048_CR25","doi-asserted-by":"publisher","first-page":"4984","DOI":"10.1016\/j.csbj.2022.08.045","volume":"20","author":"D Li","year":"2022","unstructured":"Li D, Minkara MS (2022) Elucidating the enhanced binding affinity of a double mutant SP-D with trimannose on the influenza A virus using molecular dynamics. Comput Struct Biotechnol J 20:4984\u20135000. https:\/\/doi.org\/10.1016\/j.csbj.2022.08.045","journal-title":"Comput Struct Biotechnol J"},{"issue":"1","key":"5048_CR26","doi-asserted-by":"publisher","DOI":"10.1177\/03000605221149879","volume":"51","author":"SG Li","year":"2023","unstructured":"Li SG, Liang H, Chen YW, Pang YS (2023) Death in children with influenza A (H3N2) virus infection-associated encephalopathy: two case reports. J Int Med Res 51(1):3000605221149879. https:\/\/doi.org\/10.1177\/03000605221149879","journal-title":"J Int Med Res"},{"issue":"6","key":"5048_CR27","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.immuni.2020.10.023","volume":"53","author":"H Liu","year":"2020","unstructured":"Liu H, Wu NC, Yuan M, Bangaru S, Torres JL, Caniels TG, van Schooten J, Zhu X, Lee CD, Brouwer PJM, van Gils MJ, Sanders RW, Ward AB, Wilson IA (2020) Cross-neutralization of a SARS-CoV-2 antibody to a functionally conserved site is mediated by avidity. Immunity 53(6):1272-1280.e5. https:\/\/doi.org\/10.1016\/j.immuni.2020.10.023","journal-title":"Immunity"},{"key":"5048_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2024.199465","volume":"350","author":"H Lu","year":"2024","unstructured":"Lu H, Shao J, Liu W, Gao S, Zhou G, Ning X, Huang H, Liu Y, Chang H (2024) Screening and identification of linear B-cell epitopes on structural proteins of African swine fever virus. Virus Res 350:199465. https:\/\/doi.org\/10.1016\/j.virusres.2024.199465","journal-title":"Virus Res"},{"key":"5048_CR29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/B978-0-443-13395-4.00001-0","volume-title":"Reverse vaccinology","author":"SK Mishra","year":"2024","unstructured":"Mishra SK, Pandya M, Bhatt T, Georrge JJ (2024) Chapter 11 - Reverse vaccinology 2.0: computational resources for B-cell epitope prediction. In: Das J, Dave S, Soares S, Tiwari S (eds) Reverse vaccinology. Academic Press, pp 203\u2013216"},{"key":"5048_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2025.127883","volume":"433","author":"SK Mishra","year":"2025","unstructured":"Mishra SK, Siddiquee NH, Patel CN, Kumar N, Senathilake KS, Georrge JJ (2025) Integrated immunoinformatics and reverse vaccinology assisted novel multi-epitope vaccine against Coxsackievirus A10 investigating its whole genome encoded polyprotein. J Mol Liq 433:127883. https:\/\/doi.org\/10.1016\/j.molliq.2025.127883","journal-title":"J Mol Liq"},{"issue":"1","key":"5048_CR31","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1186\/s12879-025-11066-3","volume":"25","author":"S Mohammadipour","year":"2025","unstructured":"Mohammadipour S, Tavakkoli H, Fatemi SN, Sharifi A, Mahmoudi P (2025) Designing a multi-epitope universal vaccine for concurrent infections of SARS-CoV-2 and influenza viruses using an immunoinformatics approach. BMC Infect Dis 25(1):688. https:\/\/doi.org\/10.1186\/s12879-025-11066-3","journal-title":"BMC Infect Dis"},{"key":"5048_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/813047","volume":"2015","author":"JE Mu\u00f1oz-Medina","year":"2015","unstructured":"Mu\u00f1oz-Medina JE, S\u00e1nchez-Vallejo CJ, M\u00e9ndez-Tenorio A, Monroy-Mu\u00f1oz IE, Angeles-Mart\u00ednez J, Santos Coy-Arechavaleta A, Santacruz-Tinoco CE, Gonz\u00e1lez-Ibarra J, Anguiano-Hern\u00e1ndez YM, Gonz\u00e1lez-Bonilla CR, Ram\u00f3n-Gallegos E, D\u00edaz-Qui\u00f1onez JA (2015) In Silico identification of highly conserved epitopes of influenza A H1N1, H2N2, H3N2, and H5N1 with diagnostic and vaccination potential. Biomed Res Int 2015:813047. https:\/\/doi.org\/10.1155\/2015\/813047","journal-title":"Biomed Res Int"},{"issue":"1","key":"5048_CR33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/nrmicro.2017.146","volume":"16","author":"VN Petrova","year":"2018","unstructured":"Petrova VN, Russell CA (2018) The evolution of seasonal influenza viruses. Nat Rev Microbiol 16(1):60. https:\/\/doi.org\/10.1038\/nrmicro.2017.146","journal-title":"Nat Rev Microbiol"},{"issue":"7","key":"5048_CR34","doi-asserted-by":"publisher","first-page":"453","DOI":"10.7326\/m19-0735","volume":"172","author":"O Pleguezuelos","year":"2020","unstructured":"Pleguezuelos O, Dille J, de Groen S, Oftung F, Niesters HGM, Islam MA, N\u00e6ss LM, Hungnes O, Aldarij N, Idema DL, Perez AF, James E, Frijlink HW, Stoloff G, Groeneveld P, Hak E (2020) Immunogenicity, safety, and efficacy of a standalone universal influenza vaccine, FLU-v, in healthy adults: a randomized clinical trial. Ann Intern Med 172(7):453\u2013462. https:\/\/doi.org\/10.7326\/m19-0735","journal-title":"Ann Intern Med"},{"key":"5048_CR35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/978-1-0716-0389-5_6","volume":"2131","author":"J Ramana","year":"2020","unstructured":"Ramana J, Mehla K (2020) Immunoinformatics and epitope prediction. Methods Mol Biol 2131:155\u2013171. https:\/\/doi.org\/10.1007\/978-1-0716-0389-5_6","journal-title":"Methods Mol Biol"},{"issue":"7","key":"5048_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-024-04022-6","volume":"14","author":"A Roy","year":"2024","unstructured":"Roy A, Swetha RG, Basu S, Biswas R, Ramaiah S, Anbarasu A (2024) Integrating pan-genome and reverse vaccinology to design multi-epitope vaccine against Herpes simplex virus type-1. 3 Biotech 14(7):176. https:\/\/doi.org\/10.1007\/s13205-024-04022-6","journal-title":"3 Biotech"},{"key":"5048_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10111785","author":"Z Salod","year":"2022","unstructured":"Salod Z, Mahomed O (2022) Mapping potential vaccine candidates predicted by VaxiJen for different viral pathogens between 2017-2021-a scoping review. Vaccines. https:\/\/doi.org\/10.3390\/vaccines10111785","journal-title":"Vaccines"},{"issue":"6","key":"5048_CR38","doi-asserted-by":"publisher","first-page":"6059","DOI":"10.1007\/s11030-025-11124-7","volume":"29","author":"M Samantaray","year":"2025","unstructured":"Samantaray M, Pushan SS, Rajagopalan M, Abrol K, Basumatari J, Murthy TPK, Ramaswamy A (2025) Designing a multi-epitope vaccine candidate against pandemic influenza a virus: an immunoinformatics and structural vaccinology approach. Mol Divers 29(6):6059\u20136078. https:\/\/doi.org\/10.1007\/s11030-025-11124-7","journal-title":"Mol Divers"},{"key":"5048_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac174","author":"N Sharma","year":"2022","unstructured":"Sharma N, Naorem LD, Jain S, Raghava GPS (2022) ToxinPred2: an improved method for predicting toxicity of proteins. Brief Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbac174","journal-title":"Brief Bioinform"},{"issue":"40","key":"5048_CR40","doi-asserted-by":"publisher","first-page":"5366","DOI":"10.1016\/j.vaccine.2017.08.021","volume":"35","author":"G Smith","year":"2017","unstructured":"Smith G, Liu Y, Flyer D, Massare MJ, Zhou B, Patel N, Ellingsworth L, Lewis M, Cummings JF, Glenn G (2017) Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M\u2122 adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes. Vaccine 35(40):5366\u20135372. https:\/\/doi.org\/10.1016\/j.vaccine.2017.08.021","journal-title":"Vaccine"},{"key":"5048_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.126847","volume":"50","author":"M Soens","year":"2025","unstructured":"Soens M, Ananworanich J, Hicks B, Lucas KJ, Cardona J, Sher L, Livermore G, Schaefers K, Henry C, Choi A, Avanesov A, Chen R, Du E, Pucci A, Das R, Miller J, Nachbagauer R (2025) A phase 3 randomized safety and immunogenicity trial of mRNA-1010 seasonal influenza vaccine in adults. Vaccine 50:126847. https:\/\/doi.org\/10.1016\/j.vaccine.2025.126847","journal-title":"Vaccine"},{"issue":"7902","key":"5048_CR42","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41586-022-04411-y","volume":"603","author":"R Viana","year":"2022","unstructured":"Viana R, Moyo S, Amoako DG, Tegally H, Scheepers C, Althaus CL, Anyaneji UJ, Bester PA, Boni MF, Chand M, Choga WT, Colquhoun R, Davids M, Deforche K, Doolabh D, du Plessis L, Engelbrecht S, Everatt J, Giandhari J, Giovanetti M, Hardie D, Hill V, Hsiao NY, Iranzadeh A, Ismail A, Joseph C, Joseph R, Koopile L, Kosakovsky Pond SL, Kraemer MUG, Kuate-Lere L, Laguda-Akingba O, Lesetedi-Mafoko O, Lessells RJ, Lockman S, Lucaci AG, Maharaj A, Mahlangu B, Maponga T, Mahlakwane K, Makatini Z, Marais G, Maruapula D, Masupu K, Matshaba M, Mayaphi S, Mbhele N, Mbulawa MB, Mendes A, Mlisana K, Mnguni A, Mohale T, Moir M, Moruisi K, Mosepele M, Motsatsi G, Motswaledi MS, Mphoyakgosi T, Msomi N, Mwangi PN, Naidoo Y, Ntuli N, Nyaga M, Olubayo L, Pillay S, Radibe B, Ramphal Y, Ramphal U, San JE, Scott L, Shapiro R, Singh L, Smith-Lawrence P, Stevens W, Strydom A, Subramoney K, Tebeila N, Tshiabuila D, Tsui J, van Wyk S, Weaver S, Wibmer CK, Wilkinson E, Wolter N, Zarebski AE, Zuze B, Goedhals D, Preiser W, Treurnicht F, Venter M, Williamson C, Pybus OG, Bhiman J, Glass A, Martin DP, Rambaut A, Gaseitsiwe S, von Gottberg A, de Oliveira T (2022) Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature 603(7902):679\u2013686. https:\/\/doi.org\/10.1038\/s41586-022-04411-y","journal-title":"Nature"},{"key":"5048_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2025.110700","volume":"613","author":"F Wang","year":"2026","unstructured":"Wang F, Wang S, Tong L, Wang H, Chen H, Wang X, Yin X, Sun Y, Gao X, Ren S (2026) Sequencing of the cDNA variable region of a lumpy skin disease virus ORF123 monoclonal antibody and its cross-neutralizing activity analyses against Capripoxvirus members. Virology 613:110700. https:\/\/doi.org\/10.1016\/j.virol.2025.110700","journal-title":"Virology"},{"issue":"12","key":"5048_CR44","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.02145-25","volume":"16","author":"AP Werner","year":"2025","unstructured":"Werner AP, Schneider CG, Akin EH, Hayes J, Fenstermacher KZJ, Rothman RE, Coughlan L, Pekosz A (2025) Low levels of influenza H5N1 HA and NA antibodies in the human population are boosted by seasonal H1N1 infection but not by H3N2 infection or influenza vaccination. Mbio 16(12):e0214525. https:\/\/doi.org\/10.1128\/mbio.02145-25","journal-title":"Mbio"},{"issue":"5796","key":"5048_CR45","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/289373a0","volume":"289","author":"DC Wiley","year":"1981","unstructured":"Wiley DC, Wilson IA, Skehel JJ (1981) Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289(5796):373\u2013378. https:\/\/doi.org\/10.1038\/289373a0","journal-title":"Nature"},{"issue":"2","key":"5048_CR46","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ygeno.2012.06.003","volume":"100","author":"KW Wu","year":"2012","unstructured":"Wu KW, Chien CY, Li SW, King CC, Chang CH (2012) Highly conserved influenza A virus epitope sequences as candidates of H3N2 flu vaccine targets. Genomics 100(2):102\u2013109. https:\/\/doi.org\/10.1016\/j.ygeno.2012.06.003","journal-title":"Genomics"},{"key":"5048_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1192651","volume":"13","author":"J Wu","year":"2023","unstructured":"Wu J, Nan W, Peng G, Hu H, Xu C, Huang J, Xiao Z (2023) Screening of linear B-cell epitopes and its proinflammatory activities of Haemophilus parasuis outer membrane protein P2. Front Cell Infect Microbiol 13:1192651. https:\/\/doi.org\/10.3389\/fcimb.2023.1192651","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"5048_CR48","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.bpj.2012.01.043","volume":"102","author":"Z Xia","year":"2012","unstructured":"Xia Z, Huynh T, Kang SG, Zhou R (2012) Free-energy simulations reveal that both hydrophobic and polar interactions are important for influenza hemagglutinin antibody binding. Biophys J 102(6):1453\u20131461. https:\/\/doi.org\/10.1016\/j.bpj.2012.01.043","journal-title":"Biophys J"},{"key":"5048_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2022.198815","volume":"317","author":"F Yang","year":"2022","unstructured":"Yang F, Zhu L, Liu F, Cheng L, Yao H, Wu N, Wu H, Li L (2022) Generation and characterization of monoclonal antibodies against the hemagglutinin of H3N2 influenza A viruses. Virus Res 317:198815. https:\/\/doi.org\/10.1016\/j.virusres.2022.198815","journal-title":"Virus Res"},{"issue":"1","key":"5048_CR50","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2023.2213793","volume":"15","author":"Y Zhang","year":"2023","unstructured":"Zhang Y (2023) Evolution of phage display libraries for therapeutic antibody discovery. Mabs 15(1):2213793. https:\/\/doi.org\/10.1080\/19420862.2023.2213793","journal-title":"Mabs"},{"key":"5048_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13010081","author":"S Zhao","year":"2025","unstructured":"Zhao S, Luo J, Guo W, Li L, Pu S, Dong L, Zhu W, Gao R (2025) The development of a novel broad-spectrum influenza polypeptide vaccine based on multi-epitope tandem sequences. Vaccines. https:\/\/doi.org\/10.3390\/vaccines13010081","journal-title":"Vaccines"},{"key":"5048_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/v14051031","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, Song K, Cai K, Liu L, Tang D, Long W, Zhai B, Chen J, Tao Y, Zhao Y, Liang S, Huang Q, Liu Q, Zhang Q, Chen Y, Liu Y, Li H, Wang P, Lan K, Liu H, Xu K (2022) B-cell-epitope-based fluorescent quantum dot biosensors for SARS-CoV-2 enable highly sensitive COVID-19 antibody detection. Viruses. https:\/\/doi.org\/10.3390\/v14051031","journal-title":"Viruses"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-05048-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-026-05048-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-05048-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:05:33Z","timestamp":1793030733000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-026-05048-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["5048"],"URL":"https:\/\/doi.org\/10.1007\/s00203-026-05048-5","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"28 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no potential conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments involving hazardous chemicals were conducted in fume hoods or biological safety cabinets to ensure the health and safety of laboratory personnel. The animal experimental protocol involved in this study was reviewed and approved by the Ethics Committee, Longhu Laboratory of Advanced Immunology (LHLab-HNZD-2023 002). Throughout the experimental process, we strictly adhered to animal welfare and ethical requirements, ensuring the basic welfare of the animals in terms of husbandry, daily care, and humane endpoints.","order":2,"name":"Ethics","label":"Animal ethics statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"539"}}